Iron Status in Patients with Pre-dialysis Chronic Kidney Disease in a Tertiary Hospital in North-central Nigeria

Main Article Content

Dapo Sunday Oyedepo
Timothy O Olanrewaju
https://orcid.org/0000-0002-8944-4198
Kudirat Abimbola Busari
https://orcid.org/0000-0002-9079-8751
Adegboyega Emmanuel Faponle
Emmanuel Oladipo Sanni
Adindu Chijioke
Ademola Aderibigbe
Titilope Adetoun Bamikefa
https://orcid.org/0000-0003-4837-2471

Abstract

Anaemia in CKD is associated with poor quality of life and cardiovascular disease. Iron deficiency anaemia contributes to the anaemia burden in patients with CKD but studies on iron status in patients with non-dialysis-dependent CKD in Nigeria are sparse. The aim of the study, therefore, is to determine the iron status of patients with CKD in a tertiary hospital in North-central Nigeria. We conducted a cross-sectional study on 130 patients with pre-dialysis CKD. We obtained data on the socio-demography, and aetiology of CKD. We assessed the complete blood count, serum ferritin, transferrin, iron, total iron binding capacity (TIBC), transferrin saturation (TSAT), and serum creatinine. CKD epidemiology collaboration (CKD-EPI) was used to estimate the glomerular filtration rate (eGFR). The mean age of the study participants was 55 ± 15 years with a male-to-female ratio of 2.3: 1. The mean haemoglobin was 9.8±2.2g/dl and was worse as eGFR declined. Iron deficiency anaemia was present in 27.7% of the patients (17.7% had functional iron deficiency while 10% had absolute iron deficiency). The median serum ferritin was 257.50 (102.75 – 465.00) ng/ml, serum transferrin 298.00 (216.00 – 343.25) mg/dl, serum iron was 21.85 (11.80 – 29.63) umol/l, TIBC 74.00 (54.00 – 84.65) umol/l, and TSAT of 32.55 (19.06 – 43.00) %. There was no significant association between Iron deficiency anaemia and age, or gender. Functional iron deficiency is the major contributor to iron deficiency anaemia in our patients with pre-dialysis CKD. An initial assessment of iron status is recommended for patients with CKD, to inform early treatment.

Metrics

Metrics Loading ...

Article Details

How to Cite
1.
Oyedepo DS, Olanrewaju TO, Busari KA, Faponle AE, Sanni EO, Chijioke A, Aderibigbe A, Bamikefa TA. Iron Status in Patients with Pre-dialysis Chronic Kidney Disease in a Tertiary Hospital in North-central Nigeria. Wes J Med Biomed Sci [Internet]. 2022 Dec. 20 [cited 2024 Dec. 29];3(3-4):75-81. Available from: https://wjmbs.emej.com.ng/index.php/wjmbs/article/view/123
Section
Original Article

References

Erslev AJ, Besarab A. Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int. 1997;51(3):622-630.

2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med. 2004;351(13):1296-1305.

Akinsola A, Durosinmi M, Akinola N. The haematological profile of Nigerians with chronic renal failure. Afr J Med Med Sci. 2000;29(1):13-63.

Ijoma C, Ulasi I, Ijoma U, Ifebunandu N. High prevalence of anaemia in predialysis patients in Enugu, Nigeria. Nephrol Rev. 2010;2(e14): e14.

Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, D Toto R. Anemia and end stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int. 2004;66(3):1131-1138.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med. 2004;351(13):1296-1305.

Fishbane S, Pollack S, Feldman HI, Joffe MM. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988–2004. Clin J Am Soc Nephrol. 2009;4(1):57-61.

Makusidi AM, Chijioke A, Biliaminu SA, Shittu AO, Sanni,MA, Abdul-Rahman M.B, et al. Assessment of correlation between Serum Ferritin and C-reactive protein levels in Dialysis Naïve Chronic Kidney Disease Patients in a Nigerian Tertiary Hospital. assessed on 26/08/22.

Muniyandi D, Shanmugam N, Ramanathan K, Vijayaraghavan B, Padmanabhan G. Prevalence of Iron Deficiency Anemia among Chronic Kidney Disease Patients in Kaveri Delta Region, Tamilnadu, India. Journal of Advances in Medicine and Medical Research. 2016 May 18:1-6.

Toima S, Madkour M, Saleh A, Hammam O, Raafat M. Hepcidin and iron status in chronic kidney disease. African Journal of Nephrology. 2010 Jan 1;14(1):16-23.

Gangadhar T, Srikanth P, Suneetha Y. Predictive value of iron store markers in anemia of chronic kidney disease. J Chem Pharm Res. 2010;2(3):400-410.

Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis. 2001;37(3) 564-57218.

Locatelli F, Nissenson AR, Barrett BJ, Walker RG, Wheeler DC, Eckardt KU, et al. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2008;74(10):1237-1240.

Thakur V, Kumar R. Assessment of Iron Status in Chronic Kidney Disease (CKD) Patients from India. Int J Sci Res.2013; 3:1-150.

Mohammed A. Evaluation of Iron status in chronic kidney disease patients inAhmadu Bello University Teaching Hospital, Zaria. A dissertation submitted to the postgraduate school of Ahmadu Bello University. May 2015. Assessed on 14/07/2022.

Locatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, et al. Kidney Disease: Improving Global Outcomes guidelines on anaemia management of chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transpl. 2013;28(6):1346-1359.

Deori R, Bhuyan B. Iron status in chronic kidney disease patients. Int J Res Med Sci. 2017;4(8):3229-3234.

Arogundade F, Soyinka F, Sanusi A, Ojo O, Akinsola A. Iron status and benefit of the use of parenteral iron therapy in pre-dialysis chronic kidney disease patients. Nig Postgrad Med J. 2013;20(4):299-304.

Raji YR, Ajayi SO, Akingbola TS, Adebiyi OA, Adedapo KS, Salako BL. Assessment of iron deficiency anaemia and its risk factors among adults with chronic kidney disease in a tertiary hospital in Nigeria. Nig Postgrad Med J. 2018;25(4):197-203..

Łukaszyk E, Łukaszyk M, Koc-Żórawska E, Tobolczyk J, Bodzenta-Łukaszyk A, Małyszko J. Iron Status and Inflammation in Early Stages of Chronic Kidney Disease. Kidney Bld Press Res. 2015;40(4):366-373.

Iyawe IO, Adejumo OA, Iyawe LI, Oviasu EO. Assessment of iron status in predialy sis chronic kidney disease patients in a Nigerian Tertiary Hospital. Saudi J Kidney Dis Transpl: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2018;29(6):1431-1440.

Aoun M, Karam R, Sleilaty G, Antoun L, Ammar W. Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern? PloS One. 2018;13(1): e0191541.

Rubab Z, Amin H, Abbas K, Hussain S, Ullah MI, Mohsin S. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis. Saudi J Kidney Dis Transpl. 2015;26(1):19.

Branten AJ, Swinkels DW, Klasen IS, Wetzels JF. Serum ferritin levels are increased in patients with glomerular diseases and proteinuria. Nephrol Dial Transpl. 2004;19(11):2754-2760.

Gupta S, Uppal B, Pawar B. Is soluble transferrin receptor a good marker of iron deficiency anemia in chronic kidney disease patients? Indian J Nephrol. 2009;19(3):96.